Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Campaign Reminds Doctors Of 14 August Deadline For Licensing Decision - General Medical Council (GMC), UK
Doctors are being reminded to contact the GMC with their licensing decision through an advertising campaign launched yesterday, 1 August. Adverts will appear in the medical trade press throughout the first half of August as a final push to encourage doctors to respond to the GMC.
generic viagra online
Migraines More Prevalent In Women
Headaches are a widespread problem in the United States, affecting roughly 45 million people. Migraine headaches affect millions of Americans each year they are the most common type of headache that sends patients running to their doctor"s office. Migraines occur when constricting blood vessels in the brain cause intense, recurring vascular headaches. Like other forms of headaches, women suffer from migraines more frequently than men.
News of the day
New Centre In London To Accelerate Personalized Mental Health Care
A powerful new research facility at the heart of King"s Health Partners Academic Health Sciences Centre has been launched by Professor Dame Sally C Davies, Director General of Research and Development and Chief Scientific Adviser, Department of Health. The Biomedical Research Centre (BRC) Nucleus is funded by a ÷£3M infrastructure grant from South London and Maudsley Charitable Funds (÷£1.8M) and Guy"s and St Thomas" Charity (÷£1.2M) to create a unique centre housing key translational initiatives to support the development of novel therapies and treatments for mental health and related disorders.
Endocrinology

Canada And European Communities End World Trade Organization Biotech Dispute

Canada and the European Communities announced the end of a six-year World Trade Organization (WTO) dispute regarding the approval and marketing of biotechnology products. Sharon Bomer Lauritsen, Executive Vice President, Food and Agriculture for the Biotechnology Industry Organization (BIO), issued the following statement in response: "While it is a good sign to see that Canadian canola growers have gained some access for their exports, the European Union"s approval system for agricultural biotechnology products continues to be broken. It is plagued by political interference, undue delay and member state prohibitions. "There are now 70 products awaiting approvals - compared to 40 last year. There are no new cultivation approvals - in fact - France and Germany have imposed cultivation bans within the past two years. In addition, biotech corn is still not moving into the EU. "This situation impedes U.S. trade, despite the well-documented safety of agricultural biotechnology which has produced real results towards increasing crop yields, reducing production inputs and enhancing environmental sustainability. "The EU"s non-functioning biotech approval process has blocked U.S. agricultural exports to the detriment of American farmers and agribusiness, but also has prevented European farmers from benefiting from modern technologies that are used in 25 countries by 13.3 million farmers around the world. "Trade problems will continue to exist until Europe has a science-based, timely and predictable approval process, which could be achieved if the EU simply followed its own laws and regulations. "We urge the European Commission to normalize trade of products produced through biotechnology in a timely and science-based manner." BIO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009